Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Jul 1;373(Pt 1):211–220. doi: 10.1042/BJ20030175

Cytosolic glucocorticoid receptor interaction with nuclear factor-kappa B proteins in rat liver cells.

Christina Widén 1, Jan-Ake Gustafsson 1, Ann-Charlotte Wikström 1
PMCID: PMC1223476  PMID: 12672265

Abstract

The glucocorticoid receptor (GR) acts as an anti-inflammatory factor. To a large extent, this activity is exerted by the interference of pro-inflammatory nuclear factor kappa B (NF-kappa B) activity. In their respective inactive forms, both GR and NF-kappa B reside in the cytoplasm and translocate to the nucleus on relevant stimulation. Previously, p65, a component of the NF-kappa B complex, and GR have been shown to interact physically in vitro, and the interaction is assumed to take place in the nucleus of cells [McKay and Cidlowski (1999) Endocrine Rev. 20, 435-459]. We have studied the interaction between GR and NF-kappa B using in vivo -like conditions. Using immunoaffinity chromatography or immunoprecipitation, combined with Western blotting, we observed that, with endogenous protein levels in cytosolic extracts of rat liver and of H4-II-E-C3 hepatoma cells and in contrast with the current belief, p65, p50 and inhibitory kappa B alpha complex interact with GR, even in the absence of glucocorticoid or an inflammatory signal. The interaction between non-liganded/non-activated GR and p65/p50 has also been verified by both p65 and p50 co-immunoprecipitations. Intracellular localization studies, using Western blotting, revealed that glucocorticoids can decrease tumour necrosis factor alpha (TNFalpha)-induced nuclear entry of p65, whereas glucocorticoid-induced GR translocation was much less affected by TNFalpha. We were also able to demonstrate a nuclear interaction of GR and p65 and p50 using in vivo -like protein concentrations. Furthermore, nuclear GR interaction with heat-shock protein 90 was enhanced distinctly by TNFalpha treatment. In conclusion, our studies suggest a strong interconnectivity between the NF-kappa B and GR-signalling pathways where also, somewhat unexpectedly, a physical interaction in the cytosol constitutes an integral part of GR-NF-kappa B cross-talk.

Full Text

The Full Text of this article is available as a PDF (274.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adcock I. M. Glucocorticoid-regulated transcription factors. Pulm Pharmacol Ther. 2001;14(3):211–219. doi: 10.1006/pupt.2001.0283. [DOI] [PubMed] [Google Scholar]
  2. Akner G., Mossberg K., Sundqvist K. G., Gustafsson J. A., Wikström A. C. Evidence for reversible, non-microtubule and non-microfilament-dependent nuclear translocation of hsp90 after heat shock in human fibroblasts. Eur J Cell Biol. 1992 Aug;58(2):356–364. [PubMed] [Google Scholar]
  3. Baeuerle P. A., Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science. 1988 Oct 28;242(4878):540–546. doi: 10.1126/science.3140380. [DOI] [PubMed] [Google Scholar]
  4. Caldenhoven E., Liden J., Wissink S., Van de Stolpe A., Raaijmakers J., Koenderman L., Okret S., Gustafsson J. A., Van der Saag P. T. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol. 1995 Apr;9(4):401–412. doi: 10.1210/mend.9.4.7659084. [DOI] [PubMed] [Google Scholar]
  5. Carrasco D., Cheng J., Lewin A., Warr G., Yang H., Rizzo C., Rosas F., Snapper C., Bravo R. Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein. J Exp Med. 1998 Apr 6;187(7):973–984. doi: 10.1084/jem.187.7.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Csermely P., Schnaider T., Soti C., Prohászka Z., Nardai G. The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol Ther. 1998 Aug;79(2):129–168. doi: 10.1016/s0163-7258(98)00013-8. [DOI] [PubMed] [Google Scholar]
  7. De Bosscher K., Vanden Berghe W., Vermeulen L., Plaisance S., Boone E., Haegeman G. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):3919–3924. doi: 10.1073/pnas.97.8.3919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ding G. J., Fischer P. A., Boltz R. C., Schmidt J. A., Colaianne J. J., Gough A., Rubin R. A., Miller D. K. Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. J Biol Chem. 1998 Oct 30;273(44):28897–28905. doi: 10.1074/jbc.273.44.28897. [DOI] [PubMed] [Google Scholar]
  9. Doucas V., Shi Y., Miyamoto S., West A., Verma I., Evans R. M. Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):11893–11898. doi: 10.1073/pnas.220413297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Haché R. J., Tse R., Reich T., Savory J. G., Lefebvre Y. A. Nucleocytoplasmic trafficking of steroid-free glucocorticoid receptor. J Biol Chem. 1999 Jan 15;274(3):1432–1439. doi: 10.1074/jbc.274.3.1432. [DOI] [PubMed] [Google Scholar]
  11. Li Qiutang, Verma Inder M. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002 Oct;2(10):725–734. doi: 10.1038/nri910. [DOI] [PubMed] [Google Scholar]
  12. Liden J., Delaunay F., Rafter I., Gustafsson J., Okret S. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation. J Biol Chem. 1997 Aug 22;272(34):21467–21472. doi: 10.1074/jbc.272.34.21467. [DOI] [PubMed] [Google Scholar]
  13. Liden J., Rafter I., Truss M., Gustafsson J. A., Okret S. Glucocorticoid effects on NF-kappaB binding in the transcription of the ICAM-1 gene. Biochem Biophys Res Commun. 2000 Jul 14;273(3):1008–1014. doi: 10.1006/bbrc.2000.3079. [DOI] [PubMed] [Google Scholar]
  14. McEwan I. J., Almlöf T., Wikström A. C., Dahlman-Wright K., Wright A. P., Gustafsson J. A. The glucocorticoid receptor functions at multiple steps during transcription initiation by RNA polymerase II. J Biol Chem. 1994 Oct 14;269(41):25629–25636. [PubMed] [Google Scholar]
  15. McKay L. I., Cidlowski J. A. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol. 1998 Jan;12(1):45–56. doi: 10.1210/mend.12.1.0044. [DOI] [PubMed] [Google Scholar]
  16. McKay L. I., Cidlowski J. A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev. 1999 Aug;20(4):435–459. doi: 10.1210/edrv.20.4.0375. [DOI] [PubMed] [Google Scholar]
  17. McNally J. G., Müller W. G., Walker D., Wolford R., Hager G. L. The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science. 2000 Feb 18;287(5456):1262–1265. doi: 10.1126/science.287.5456.1262. [DOI] [PubMed] [Google Scholar]
  18. Nemoto T., Ohara-Nemoto Y., Denis M., Gustafsson J. A. The transformed glucocorticoid receptor has a lower steroid-binding affinity than the nontransformed receptor. Biochemistry. 1990 Feb 20;29(7):1880–1886. doi: 10.1021/bi00459a031. [DOI] [PubMed] [Google Scholar]
  19. Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax. 2000 Jul;55(7):603–613. doi: 10.1136/thorax.55.7.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nissen R. M., Yamamoto K. R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 2000 Sep 15;14(18):2314–2329. doi: 10.1101/gad.827900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Okret S., Wikström A. C., Wrange O., Andersson B., Gustafsson J. A. Monoclonal antibodies against the rat liver glucocorticoid receptor. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1609–1613. doi: 10.1073/pnas.81.6.1609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pratt W. B., Toft D. O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev. 1997 Jun;18(3):306–360. doi: 10.1210/edrv.18.3.0303. [DOI] [PubMed] [Google Scholar]
  23. Ray A., Prefontaine K. E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):752–756. doi: 10.1073/pnas.91.2.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Scheinman R. I., Gualberto A., Jewell C. M., Cidlowski J. A., Baldwin A. S., Jr Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol. 1995 Feb;15(2):943–953. doi: 10.1128/mcb.15.2.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Widén C., Zilliacus J., Gustafsson J. A., Wikström A. C. Glucocorticoid receptor interaction with 14-3-3 and Raf-1, a proposed mechanism for cross-talk of two signal transduction pathways. J Biol Chem. 2000 Dec 15;275(50):39296–39301. doi: 10.1074/jbc.M006943200. [DOI] [PubMed] [Google Scholar]
  26. Wikström A. C., Bakke O., Okret S., Brönnegård M., Gustafsson J. A. Intracellular localization of the glucocorticoid receptor: evidence for cytoplasmic and nuclear localization. Endocrinology. 1987 Apr;120(4):1232–1242. doi: 10.1210/endo-120-4-1232. [DOI] [PubMed] [Google Scholar]
  27. Wissink S., van Heerde E. C., Schmitz M. L., Kalkhoven E., van der Burg B., Baeuerle P. A., van der Saag P. T. Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J Biol Chem. 1997 Aug 29;272(35):22278–22284. doi: 10.1074/jbc.272.35.22278. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES